JP2025098147A5 - - Google Patents
Info
- Publication number
- JP2025098147A5 JP2025098147A5 JP2025049941A JP2025049941A JP2025098147A5 JP 2025098147 A5 JP2025098147 A5 JP 2025098147A5 JP 2025049941 A JP2025049941 A JP 2025049941A JP 2025049941 A JP2025049941 A JP 2025049941A JP 2025098147 A5 JP2025098147 A5 JP 2025098147A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- fat
- ligand
- composition according
- target
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL264112A IL264112A (en) | 2019-01-06 | 2019-01-06 | An a3 adenosine receptor ligand for use for reducing level of adipocytes |
| IL264112 | 2019-01-06 | ||
| JP2021539140A JP2022517753A (ja) | 2019-01-06 | 2020-01-05 | 脂肪減少効果の達成に使用するためのａ３アデノシン受容体リガンド |
| JP2023078136A JP2023100928A (ja) | 2019-01-06 | 2023-05-10 | 脂肪減少効果の達成に使用するためのａ３アデノシン受容体リガンド |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023078136A Division JP2023100928A (ja) | 2019-01-06 | 2023-05-10 | 脂肪減少効果の達成に使用するためのａ３アデノシン受容体リガンド |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025098147A JP2025098147A (ja) | 2025-07-01 |
| JP2025098147A5 true JP2025098147A5 (enExample) | 2026-04-06 |
| JP7894175B2 JP7894175B2 (ja) | 2026-07-23 |
Family
ID=65656120
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021539140A Pending JP2022517753A (ja) | 2019-01-06 | 2020-01-05 | 脂肪減少効果の達成に使用するためのａ３アデノシン受容体リガンド |
| JP2023078136A Pending JP2023100928A (ja) | 2019-01-06 | 2023-05-10 | 脂肪減少効果の達成に使用するためのａ３アデノシン受容体リガンド |
| JP2025049941A Active JP7894175B2 (ja) | 2019-01-06 | 2025-03-25 | 脂肪減少効果の達成に使用するためのａ３アデノシン受容体リガンド |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021539140A Pending JP2022517753A (ja) | 2019-01-06 | 2020-01-05 | 脂肪減少効果の達成に使用するためのａ３アデノシン受容体リガンド |
| JP2023078136A Pending JP2023100928A (ja) | 2019-01-06 | 2023-05-10 | 脂肪減少効果の達成に使用するためのａ３アデノシン受容体リガンド |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12213990B2 (enExample) |
| EP (1) | EP3906034A1 (enExample) |
| JP (3) | JP2022517753A (enExample) |
| KR (1) | KR20210113279A (enExample) |
| CN (1) | CN113543790A (enExample) |
| AU (1) | AU2020205042B2 (enExample) |
| BR (1) | BR112021013084A2 (enExample) |
| CA (1) | CA3126002A1 (enExample) |
| IL (2) | IL264112A (enExample) |
| MX (1) | MX2021008172A (enExample) |
| WO (1) | WO2020141535A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT202300014340A1 (it) * | 2023-07-10 | 2025-01-10 | Consiglio Nazionale Ricerche | Trattamento di malattie associate alla disfunzione del gene ocrl. |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5443836A (en) | 1993-03-15 | 1995-08-22 | Gensia, Inc. | Methods for protecting tissues and organs from ischemic damage |
| US5688774A (en) | 1993-07-13 | 1997-11-18 | The United States Of America As Represented By The Department Of Health And Human Services | A3 adenosine receptor agonists |
| US5773423A (en) | 1993-07-13 | 1998-06-30 | The United States Of America As Represented By The Department Of Health And Human Services | A3 adenosine receptor agonists |
| AU1399297A (en) | 1996-01-24 | 1997-08-20 | Sumitomo Chemical Company, Limited | Dihalopropene compounds, their use as insecticides/acaricides and intermediates for their production |
| CA2296485A1 (en) | 1997-07-29 | 1999-02-11 | Medco Research, Inc. | N6-substituted-adenosine-5'-uronamides as adenosine receptor modulators |
| US6048865A (en) | 1997-07-29 | 2000-04-11 | Medco Research, Inc. | N6 -substituted-adenosine-5'-uronamides as adenosine receptor modulator |
| AU1363699A (en) | 1997-10-23 | 1999-05-10 | National Institute Of Health | Methods for reducing ischemic injury of the heart via the sequential administ ration of monophosphoryl lipid a and adenosine receptor agents |
| IL133680A0 (en) | 1999-09-10 | 2001-04-30 | Can Fite Technologies Ltd | Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
| US6946449B2 (en) | 2001-07-13 | 2005-09-20 | Cv Therapeutics, Inc. | Partial and full agonists of A1 adenosine receptors |
| DK1983990T3 (da) | 2006-01-26 | 2011-07-11 | Us Gov Health & Human Serv | Allosteriske A3-adenosin-receptormodulatorer |
| WO2012027695A1 (en) * | 2010-08-26 | 2012-03-01 | Northeastern University | Methods and compositions for preventing or treating obesity |
| WO2013111132A1 (en) | 2012-01-23 | 2013-08-01 | Can-Fite Biopharma Ltd. | Treatment of liver conditions |
| IL242723B (en) * | 2015-11-23 | 2019-12-31 | Can Fite Biopharma Ltd | A3 adenosine receptor ligand for the treatment of ectopic fat accumulation |
| KR101881441B1 (ko) * | 2017-01-20 | 2018-07-24 | 서울대학교산학협력단 | 다중 약리단 특성에 기반한 비정상적 아디포넥틴 관련 질환 치료용 조성물 |
-
2019
- 2019-01-06 IL IL264112A patent/IL264112A/en unknown
-
2020
- 2020-01-05 AU AU2020205042A patent/AU2020205042B2/en active Active
- 2020-01-05 BR BR112021013084-5A patent/BR112021013084A2/pt unknown
- 2020-01-05 MX MX2021008172A patent/MX2021008172A/es unknown
- 2020-01-05 JP JP2021539140A patent/JP2022517753A/ja active Pending
- 2020-01-05 WO PCT/IL2020/050011 patent/WO2020141535A1/en not_active Ceased
- 2020-01-05 EP EP20700855.8A patent/EP3906034A1/en active Pending
- 2020-01-05 KR KR1020217024682A patent/KR20210113279A/ko active Pending
- 2020-01-05 CN CN202080008167.6A patent/CN113543790A/zh active Pending
- 2020-01-05 CA CA3126002A patent/CA3126002A1/en active Pending
- 2020-01-05 US US17/309,952 patent/US12213990B2/en active Active
-
2021
- 2021-06-29 IL IL284463A patent/IL284463B2/en unknown
-
2023
- 2023-05-10 JP JP2023078136A patent/JP2023100928A/ja active Pending
-
2025
- 2025-03-25 JP JP2025049941A patent/JP7894175B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7650929B2 (ja) | 成人における焦点てんかんの処置のための合成経皮的カンナビジオール | |
| JP2009507838A5 (enExample) | ||
| HRP20161444T1 (hr) | Farmaceutski pripravci koji sadrže lokalni anestetik kao što je bupivakain za lokalnu primjenu u usta ili grlo | |
| JP2019503365A5 (enExample) | ||
| JP2007512371A5 (enExample) | ||
| JP2017533972A5 (enExample) | ||
| NZ587202A (en) | Methods for measuring a patient response upon administration of a drug and compositions thereof | |
| JP2005538190A5 (enExample) | ||
| JP2024531188A5 (enExample) | ||
| JP2024500324A5 (enExample) | ||
| JP4996803B2 (ja) | 抗高血圧剤に対する抵抗性及び関連状態を処置する方法及び処方物 | |
| RU2016137926A (ru) | Композиции грапипранта и способы их применения | |
| JP2016505050A5 (enExample) | ||
| JP2023549849A5 (enExample) | ||
| JP2012525358A5 (enExample) | ||
| JP2023531930A5 (enExample) | ||
| JP2019507786A5 (enExample) | ||
| JP2013543897A5 (enExample) | ||
| RU2008110933A (ru) | Применение амброксола для лечения риновирусных инфекций | |
| JP2024523123A (ja) | 去勢抵抗性前立腺がんの治療薬の調製におけるスタキオースの使用 | |
| JP2006508994A5 (enExample) | ||
| JP2003055205A (ja) | 抗真菌病組成物 | |
| Roopashri et al. | Radiotherapy and chemotherapy induced oral mucositis--prevention and current therapeutic modalities | |
| JP2024084670A5 (enExample) | ||
| RU2009145804A (ru) | Аксомадол для лечения боли от артроза |